RxDoctor Payments Data

Jocelyn Dee

Internal Medicine · Los Angeles, CANPI 1053495663

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $128,623 of the $174,499 with a category attached, or 73.7%. Viiv Healthcare Company accounts for 80.4% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $118,577 and has fallen 99.7% since, to $399 in 2025. Among internal medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$174,499in general payments, 2019–2025

Across 259 payments — averaging $673.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$140K
  • Gilead$31K
  • GSK$850
  • AbbVie$601
  • Johnson & Johnson$597
  • Medtronic$350
  • plus $443 from 5 others

What the payments were for

  • Consulting fees$27,15016%
  • Speaking & faculty fees$128,62374%
  • Travel & lodging$11,8347%
  • Food & beverage$6,8924%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$174,499 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California →

Other internal medicine in Los Angeles

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →